Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: A Cross-sectional study

OBJECTIVE: One of the primary reasons for hesitancy in taking COVID-19 vaccines is the fear of side effects. This study primarily aimed to inspect the potential side effects of the COVID-19 vaccines circulated in Bangladesh. Design and Settings. The study was based on a cross-sectional anonymous onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohsin, Md, Mahmud, Sultan, Uddin Mian, Ashraf, Hasan, Prottay, Muyeed, Abdul, Taif Ali, Md., Faysal Ahmed, Fee, Islam, Ariful, Maliha Rahman, Maisha, Islam, Mahfuza, Rahaman Khan, Md Hasinur, Shafiqur Rahman, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394094/
https://www.ncbi.nlm.nih.gov/pubmed/36032698
http://dx.doi.org/10.1016/j.jvacx.2022.100207
Descripción
Sumario:OBJECTIVE: One of the primary reasons for hesitancy in taking COVID-19 vaccines is the fear of side effects. This study primarily aimed to inspect the potential side effects of the COVID-19 vaccines circulated in Bangladesh. Design and Settings. The study was based on a cross-sectional anonymous online survey conducted in December 2021 across Bangladesh. Participants. The study included consenting Bangladeshi individuals aged 12 and above who had received at least one dose of the COVID-19 vaccines. Main Outcome. Analyses were carried out through exploratory analysis, Chi-square test, and logistic regression to investigate potential side effects of the COVID-19 vaccines. RESULTS: A total of 1,180 vaccinated people participated in the study. Only 39.48% of the participants reported at least one side effect after receiving their COVID-19 vaccine. Injection-site pain, fever, headache, redness/swelling at the injection site, and lethargy were the most commonly reported adverse effects, all of which were mild and lasted 1–3 days. Side effects were most prevalent (about 80%) among individuals who received Pfizer-BioNTech and Moderna vaccines and were least common among those who received Sinopharm and Sinovac vaccines (21%-28%). When compared to the Sinopharm vaccines, the OxfordAstraZeneca, Pfizer-BioNTech, and Moderna vaccines were 4.51 times (95% CI: 2.53–8.04), 5.37 times (95% CI: 2.57–11.22), and 4.28 times (95% CI: 2.28–8.05) likelier to produce side effects. Furthermore, males, those over 50 years old, urban dwellers, smokers, and those with underlying health issues had a considerably increased risk of developing side effects. A lack of confidence in vaccines' efficacy and a substantial level of hesitancy in allowing children (age five years or over) and older people (70 years or over) to receive COVID-19 vaccines were also observed. CONCLUSION: Side effects of COVID-19 vaccines are minimal, demonstrating their safety. Efforts should be made to disseminate such findings worldwide to increase vaccine uptake.

Ejemplares similares